A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-alpha/beta and TNF-alpha in cultured endothelial cells
The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lympho...
Saved in:
Published in | BMC immunology Vol. 6; no. 1; p. 6 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
07.03.2005
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV-restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb.
We examined the expression of GlcNAc6ST-2 in relationship to the MECA-79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF-alpha and lymphotoxin-alphabeta induced GlcNAc6ST-2 mRNA and protein in cultured human umbilical vein endothelial cells.
These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA. |
---|---|
AbstractList | Abstract
Background
The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV-restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb.
Results
We examined the expression of GlcNAc6ST-2 in relationship to the MECA-79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF-α and lymphotoxin-αβ induced
GlcNAc6ST-2
mRNA and protein in cultured human umbilical vein endothelial cells.
Conclusion
These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA. The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV-restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb. We examined the expression of GlcNAc6ST-2 in relationship to the MECA-79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF-alpha and lymphotoxin-alphabeta induced GlcNAc6ST-2 mRNA and protein in cultured human umbilical vein endothelial cells. These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA. Background: The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV- restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb. Results: We examined the expression of GlcNAc6ST-2 in relationship to the MECA- 79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF- alpha and lymphotoxin- alpha beta induced GlcNAc6ST-2 mRNA and protein in cultured human umbilical vein endothelial cells. Conclusions: These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA. Abstract Background The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV-restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb. Results We examined the expression of GlcNAc6ST-2 in relationship to the MECA-79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF-α and lymphotoxin-αβ induced GlcNAc6ST-2 mRNA and protein in cultured human umbilical vein endothelial cells. Conclusion These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA. BACKGROUND: The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV-restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb. RESULTS: We examined the expression of GlcNAc6ST-2 in relationship to the MECA-79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF-α and lymphotoxin-αβ induced GlcNAc6ST-2 mRNA and protein in cultured human umbilical vein endothelial cells. CONCLUSION: These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA. |
ArticleNumber | 6 |
Author | Galindo, María Rosen, Steven D Santiago, Begoña Pablos, José L Tsay, Durwin Singer, Mark S Palao, Guillermo |
AuthorAffiliation | 1 Servicio de Reumatología y Unidad de Investigación, Hospital 12 de Octubre, 28041 Madrid, Spain 2 Department of Anatomy, University of California, San Francisco, California, USA |
AuthorAffiliation_xml | – name: 2 Department of Anatomy, University of California, San Francisco, California, USA – name: 1 Servicio de Reumatología y Unidad de Investigación, Hospital 12 de Octubre, 28041 Madrid, Spain |
Author_xml | – sequence: 1 givenname: José L surname: Pablos fullname: Pablos, José L email: jlpablos@h12o.es organization: Servicio de Reumatología y Unidad de Investigación, Hospital 12 de Octubre, 28041 Madrid, Spain. jlpablos@h12o.es – sequence: 2 givenname: Begoña surname: Santiago fullname: Santiago, Begoña – sequence: 3 givenname: Durwin surname: Tsay fullname: Tsay, Durwin – sequence: 4 givenname: Mark S surname: Singer fullname: Singer, Mark S – sequence: 5 givenname: Guillermo surname: Palao fullname: Palao, Guillermo – sequence: 6 givenname: María surname: Galindo fullname: Galindo, María – sequence: 7 givenname: Steven D surname: Rosen fullname: Rosen, Steven D |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15752429$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kstu1TAQhiNURC-wZIuyYhcaJ46dbBBV1dJKFWwKW8uXcePKsQ-2U_W8Dw-K0xyVHiFWtmf--Ty34-LAeQdF8R7VnxDqySnCFFUNok1FKvKqOHp-H7y4HxbHMd7XNaJ9078pDlFHuwY3w1Hx-6y8uvhZBYgpGJlAlXG22qfAXdQQeITSxBIeN1kRs9e4MowwTzx5o0oe0hhMyoq4df7BzFPJnVoijFOzzHqxLe122ow--UfjKm43Iz8VkPiT8Pbb5WpauHK2aQ45BpzyaQRruC0lWBvfFq81txHe7c6T4sflxe35VXXz_ev1-dlNJbp2SBV0QvEOgyC47bGWSGgtuGhAI4opxaJvFAipWioHpTSlGjgmPR1IP2CVg06K65WrPL9nm2AmHrbMc8OeDD7csVyxkRZYh0iHOt5L3GKMFBWABtJiISjBtaBDZn1eWZtZTKAkuNxTuwfd9zgzsjv_wFBNh77tM-DLChDG_wew75F-YsvE2TJxRhjJiI-7HIL_NecRs8nEpaPcgZ8jy-vQYtIuyVarUAYfYwD9_A2q2bJm_4A_vCzur3q3V-0fa_7VOQ |
CitedBy_id | crossref_primary_10_1007_s00281_012_0302_3 crossref_primary_10_1097_MOG_0b013e3282f4906d crossref_primary_10_1099_vir_0_83032_0 crossref_primary_10_1186_s12951_021_00793_9 crossref_primary_10_4049_jimmunol_180_5_3467 crossref_primary_10_1016_j_it_2006_10_007 crossref_primary_10_4049_jimmunol_1701269 crossref_primary_10_1111_j_1600_065X_2009_00786_x crossref_primary_10_1002_art_22020 crossref_primary_10_3899_jrheum_100263 crossref_primary_10_1095_biolreprod_113_113654 crossref_primary_10_1248_bpb_32_774 crossref_primary_10_1093_glycob_cwp004 crossref_primary_10_1111_j_2047_2927_2014_00192_x crossref_primary_10_1016_j_cyto_2007_07_184 crossref_primary_10_1111_j_0105_2896_2009_00861_x crossref_primary_10_1093_humrep_dep247 crossref_primary_10_1002_art_37927 crossref_primary_10_3389_fimmu_2017_00045 crossref_primary_10_1038_s41551_021_00766_1 crossref_primary_10_1371_journal_pone_0091850 crossref_primary_10_3390_cells11162513 crossref_primary_10_3390_ijms25042270 crossref_primary_10_1186_1471_2172_7_12 crossref_primary_10_1371_journal_pone_0116295 crossref_primary_10_1042_BJ20100360 crossref_primary_10_1016_j_smim_2007_12_004 crossref_primary_10_3389_fneur_2022_828970 crossref_primary_10_1042_BJ20070958 crossref_primary_10_1369_0022155417753363 crossref_primary_10_1080_2162402X_2015_1008791 crossref_primary_10_1007_s10456_021_09792_8 crossref_primary_10_1016_j_clindermatol_2007_11_002 crossref_primary_10_1158_0008_5472_CAN_12_1912 crossref_primary_10_1038_ni1330 crossref_primary_10_1242_bio_021600 crossref_primary_10_1016_j_it_2022_07_002 crossref_primary_10_1111_j_1749_6632_2011_06356_x crossref_primary_10_1186_1477_7827_10_46 crossref_primary_10_1016_j_bbrc_2010_12_110 crossref_primary_10_1074_jbc_M112_363119 crossref_primary_10_1302_2046_3758_112_BJR_2021_0270_R1 crossref_primary_10_1016_j_ajpath_2010_11_009 crossref_primary_10_1073_pnas_0700334104 crossref_primary_10_1016_j_jdermsci_2009_10_001 crossref_primary_10_1093_cvr_cvt263 crossref_primary_10_1586_1744666X_4_2_173 crossref_primary_10_1080_08916930601061470 crossref_primary_10_3389_fimmu_2022_1009306 crossref_primary_10_1074_mcp_M113_028878 crossref_primary_10_1111_pin_12294 crossref_primary_10_1016_j_autrev_2015_06_006 crossref_primary_10_1007_s00011_016_0915_4 crossref_primary_10_1161_CIRCRESAHA_114_301137 |
Cites_doi | 10.1172/JCI119389 10.1083/jcb.107.5.1853 10.1084/jem.20021761 10.1016/S1074-7613(00)80083-7 10.1093/intimm/dxh128 10.1074/jbc.M109958200 10.1038/nature01661 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0 10.1002/art.20356 10.1146/annurev.immunol.21.090501.080131 10.4049/jimmunol.166.1.650 10.1016/S0002-9440(10)63722-4 10.1016/S1074-7613(01)00188-1 10.4049/jimmunol.166.7.4650 10.1186/ar751 10.1002/1529-0131(199812)41:12<2211::AID-ART17>3.0.CO;2-O 10.1182/blood.V88.9.3259.bloodjournal8893259 10.1007/BF02786481 10.4049/jimmunol.167.2.1072 10.1111/j.1749-6632.2003.tb06042.x 10.1073/pnas.0407503101 10.1016/S0092-8674(01)00394-4 10.1681/ASN.V11122358 10.1016/S0002-9440(10)62313-9 10.4049/jimmunol.170.4.2147 10.1074/jbc.M311150200 10.1038/nri1222 10.1165/ajrcmb.23.4.4113 10.1084/jem.183.4.1461 10.1016/S0002-9440(10)61114-5 10.4049/jimmunol.169.1.424 10.1016/S0002-9440(10)64210-1 10.4049/jimmunol.170.9.4638 10.1073/pnas.93.1.221 10.1084/jem.20030057 10.1084/jem.182.4.1133 10.1016/S1074-7613(00)80199-5 10.1038/nri1054 10.1074/jbc.M404456200 10.4049/jimmunol.173.10.6161 10.1242/jcs.00662 10.1126/science.282.5390.941 10.1002/art.1780261203 10.1083/jcb.145.4.899 10.1056/NEJMoa032534 |
ContentType | Journal Article |
Copyright | Copyright © 2005 Pablos et al; licensee BioMed Central Ltd. |
Copyright_xml | – notice: Copyright © 2005 Pablos et al; licensee BioMed Central Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 H94 5PM DOA |
DOI | 10.1186/1471-2172-6-6 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | CrossRef MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1471-2172 |
EndPage | 6 |
ExternalDocumentID | oai_doaj_org_article_516515a8c43441d7be19634bb7640b79 oai_biomedcentral_com_1471_2172_6_6 10_1186_1471_2172_6_6 15752429 |
Genre | Research Support, U.S. Gov't, P.H.S Comparative Study Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: R37 GM023547 – fundername: NIGMS NIH HHS grantid: R37GM23547 – fundername: NIGMS NIH HHS grantid: R01GM57411 – fundername: NIGMS NIH HHS grantid: R01 GM057411 |
GroupedDBID | --- -A0 0R~ 123 23N 2VQ 2WC 4.4 53G 5VS 6J9 AAFWJ AAJSJ ABDBF ACGFO ACGFS ACIHN ACMJI ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFPKN AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BFQNJ BMC C1A C24 C6C CGR CS3 CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESX F5P GROUPED_DOAJ GX1 H13 HYE IAO IHR INR IPNFZ KQ8 M48 M~E NPM O5R O5S OK1 P2P PGMZT RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS W2D WOQ WOW XSB AAYXX CITATION 7T5 H94 ABVAZ AFGXO AFNRJ ITC 5PM |
ID | FETCH-LOGICAL-b539t-e5bda54eb64384fc1bffbab2ef174774b82debcd37c9ddf77fea468796894d643 |
IEDL.DBID | RBZ |
ISSN | 1471-2172 |
IngestDate | Tue Oct 22 15:13:36 EDT 2024 Tue Sep 17 20:55:16 EDT 2024 Wed May 22 07:12:25 EDT 2024 Fri Oct 25 03:42:39 EDT 2024 Thu Sep 26 15:42:25 EDT 2024 Sat Nov 02 12:30:57 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b539t-e5bda54eb64384fc1bffbab2ef174774b82debcd37c9ddf77fea468796894d643 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1186/1471-2172-6-6 |
PMID | 15752429 |
PQID | 17834639 |
PQPubID | 23462 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_516515a8c43441d7be19634bb7640b79 pubmedcentral_primary_oai_pubmedcentral_nih_gov_1079838 biomedcentral_primary_oai_biomedcentral_com_1471_2172_6_6 proquest_miscellaneous_17834639 crossref_primary_10_1186_1471_2172_6_6 pubmed_primary_15752429 |
PublicationCentury | 2000 |
PublicationDate | 2005-03-07 |
PublicationDateYYYYMMDD | 2005-03-07 |
PublicationDate_xml | – month: 03 year: 2005 text: 2005-03-07 day: 07 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC immunology |
PublicationTitleAlternate | BMC Immunol |
PublicationYear | 2005 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | N Hiraoka (67_CR20) 2004; 279 M Salmi (67_CR23) 2001; 166 A Braun (67_CR47) 2004; 50 NM Carter (67_CR46) 2003; 116 A van Zante (67_CR19) 2003; 198 CM Weyand (67_CR4) 2003; 987 M Salmi (67_CR24) 1997; 99 K Shi (67_CR38) 2001; 166 UH von Andrian (67_CR8) 2003; 3 N Hiraoka (67_CR12) 1999; 11 SA Michie (67_CR25) 1993; 143 JC Yeh (67_CR13) 2001; 105 DL Drayton (67_CR28) 2003; 197 S Toppila (67_CR30) 2000; 23 AE Schroder (67_CR2) 1996; 93 JP Turunen (67_CR31) 1995; 182 K Uchimura (67_CR14) 2004; 279 J Kirveskari (67_CR32) 2000; 11 CC Reparon-Schuijt (67_CR35) 2001; 44 U Samulowitz (67_CR15) 2002; 160 A Maiti (67_CR45) 1998; 282 SA Luther (67_CR42) 2000; 12 NH Ruddle (67_CR6) 1999; 19 P Delmotte (67_CR44) 2002; 277 A Kratz (67_CR5) 1996; 183 M Kobayashi (67_CR29) 2004; 101 CC Reparon-Schuijt (67_CR36) 1998; 41 PR Streeter (67_CR17) 1988; 107 JC Edwards (67_CR37) 2004; 350 S Hemmerich (67_CR18) 2001; 15 SA Luther (67_CR41) 2002; 169 A Bistrup (67_CR11) 1999; 145 JL Pablos (67_CR40) 2003; 170 H Kanda (67_CR16) 2004; 16 RE Mebius (67_CR7) 2003; 3 SD Rosen (67_CR9) 2004; 22 DL Drayton (67_CR43) 2004; 173 A Bistrup (67_CR26) 2004; 164 AJ Freemont (67_CR22) 1983; 26 GS Kansas (67_CR10) 1996; 88 67_CR27 JJ Goronzy (67_CR34) 2003; 5 GS Firestein (67_CR1) 2003; 423 S Takemura (67_CR3) 2001; 167 J Renkonen (67_CR21) 2002; 161 SD Rosen (67_CR33) 2005; 166 W Weninger (67_CR39) 2003; 170 |
References_xml | – volume: 99 start-page: 2165 year: 1997 ident: 67_CR24 publication-title: J Clin Invest doi: 10.1172/JCI119389 contributor: fullname: M Salmi – volume: 107 start-page: 1853 year: 1988 ident: 67_CR17 publication-title: J Cell Biol doi: 10.1083/jcb.107.5.1853 contributor: fullname: PR Streeter – volume: 197 start-page: 1153 year: 2003 ident: 67_CR28 publication-title: J Exp Med doi: 10.1084/jem.20021761 contributor: fullname: DL Drayton – volume: 11 start-page: 79 year: 1999 ident: 67_CR12 publication-title: Immunity doi: 10.1016/S1074-7613(00)80083-7 contributor: fullname: N Hiraoka – volume: 16 start-page: 1265 year: 2004 ident: 67_CR16 publication-title: Int Immunol doi: 10.1093/intimm/dxh128 contributor: fullname: H Kanda – volume: 277 start-page: 424 year: 2002 ident: 67_CR44 publication-title: J Biol Chem doi: 10.1074/jbc.M109958200 contributor: fullname: P Delmotte – volume: 423 start-page: 356 year: 2003 ident: 67_CR1 publication-title: Nature doi: 10.1038/nature01661 contributor: fullname: GS Firestein – volume: 44 start-page: 41 year: 2001 ident: 67_CR35 publication-title: Arthritis Rheum doi: 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0 contributor: fullname: CC Reparon-Schuijt – volume: 50 start-page: 2140 year: 2004 ident: 67_CR47 publication-title: Arthritis Rheum doi: 10.1002/art.20356 contributor: fullname: A Braun – volume: 22 start-page: 129 year: 2004 ident: 67_CR9 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.21.090501.080131 contributor: fullname: SD Rosen – volume: 166 start-page: 650 year: 2001 ident: 67_CR38 publication-title: J Immunol doi: 10.4049/jimmunol.166.1.650 contributor: fullname: K Shi – volume: 164 start-page: 1635 year: 2004 ident: 67_CR26 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)63722-4 contributor: fullname: A Bistrup – volume: 15 start-page: 237 year: 2001 ident: 67_CR18 publication-title: Immunity doi: 10.1016/S1074-7613(01)00188-1 contributor: fullname: S Hemmerich – volume: 166 start-page: 4650 year: 2001 ident: 67_CR23 publication-title: J Immunol doi: 10.4049/jimmunol.166.7.4650 contributor: fullname: M Salmi – volume: 5 start-page: 131 year: 2003 ident: 67_CR34 publication-title: Arthritis Res Ther doi: 10.1186/ar751 contributor: fullname: JJ Goronzy – volume: 41 start-page: 2211 year: 1998 ident: 67_CR36 publication-title: Arthritis Rheum doi: 10.1002/1529-0131(199812)41:12<2211::AID-ART17>3.0.CO;2-O contributor: fullname: CC Reparon-Schuijt – volume: 88 start-page: 3259 year: 1996 ident: 67_CR10 publication-title: Blood doi: 10.1182/blood.V88.9.3259.bloodjournal8893259 contributor: fullname: GS Kansas – volume: 19 start-page: 119 year: 1999 ident: 67_CR6 publication-title: Immunol Res doi: 10.1007/BF02786481 contributor: fullname: NH Ruddle – volume: 167 start-page: 1072 year: 2001 ident: 67_CR3 publication-title: J Immunol doi: 10.4049/jimmunol.167.2.1072 contributor: fullname: S Takemura – volume: 987 start-page: 140 year: 2003 ident: 67_CR4 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2003.tb06042.x contributor: fullname: CM Weyand – volume: 143 start-page: 1688 year: 1993 ident: 67_CR25 publication-title: Am J Pathol contributor: fullname: SA Michie – volume: 101 start-page: 17807 year: 2004 ident: 67_CR29 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0407503101 contributor: fullname: M Kobayashi – volume: 105 start-page: 957 year: 2001 ident: 67_CR13 publication-title: Cell doi: 10.1016/S0092-8674(01)00394-4 contributor: fullname: JC Yeh – volume: 11 start-page: 2358 year: 2000 ident: 67_CR32 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V11122358 contributor: fullname: J Kirveskari – volume: 166 start-page: 935 year: 2005 ident: 67_CR33 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)62313-9 contributor: fullname: SD Rosen – volume: 170 start-page: 2147 year: 2003 ident: 67_CR40 publication-title: J Immunol doi: 10.4049/jimmunol.170.4.2147 contributor: fullname: JL Pablos – volume: 279 start-page: 3058 year: 2004 ident: 67_CR20 publication-title: J Biol Chem doi: 10.1074/jbc.M311150200 contributor: fullname: N Hiraoka – volume: 3 start-page: 867 year: 2003 ident: 67_CR8 publication-title: Nat Rev Immunol doi: 10.1038/nri1222 contributor: fullname: UH von Andrian – volume: 23 start-page: 492 year: 2000 ident: 67_CR30 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/ajrcmb.23.4.4113 contributor: fullname: S Toppila – volume: 183 start-page: 1461 year: 1996 ident: 67_CR5 publication-title: J Exp Med doi: 10.1084/jem.183.4.1461 contributor: fullname: A Kratz – volume: 160 start-page: 1669 year: 2002 ident: 67_CR15 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)61114-5 contributor: fullname: U Samulowitz – volume: 169 start-page: 424 year: 2002 ident: 67_CR41 publication-title: J Immunol doi: 10.4049/jimmunol.169.1.424 contributor: fullname: SA Luther – volume: 161 start-page: 543 year: 2002 ident: 67_CR21 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)64210-1 contributor: fullname: J Renkonen – ident: 67_CR27 – volume: 170 start-page: 4638 year: 2003 ident: 67_CR39 publication-title: J Immunol doi: 10.4049/jimmunol.170.9.4638 contributor: fullname: W Weninger – volume: 93 start-page: 221 year: 1996 ident: 67_CR2 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.93.1.221 contributor: fullname: AE Schroder – volume: 198 start-page: 1289 year: 2003 ident: 67_CR19 publication-title: J Exp Med doi: 10.1084/jem.20030057 contributor: fullname: A van Zante – volume: 182 start-page: 1133 year: 1995 ident: 67_CR31 publication-title: J Exp Med doi: 10.1084/jem.182.4.1133 contributor: fullname: JP Turunen – volume: 12 start-page: 471 year: 2000 ident: 67_CR42 publication-title: Immunity doi: 10.1016/S1074-7613(00)80199-5 contributor: fullname: SA Luther – volume: 3 start-page: 292 year: 2003 ident: 67_CR7 publication-title: Nat Rev Immunol doi: 10.1038/nri1054 contributor: fullname: RE Mebius – volume: 279 start-page: 35001 year: 2004 ident: 67_CR14 publication-title: J Biol Chem doi: 10.1074/jbc.M404456200 contributor: fullname: K Uchimura – volume: 173 start-page: 6161 year: 2004 ident: 67_CR43 publication-title: J Immunol doi: 10.4049/jimmunol.173.10.6161 contributor: fullname: DL Drayton – volume: 116 start-page: 3591 year: 2003 ident: 67_CR46 publication-title: J Cell Sci doi: 10.1242/jcs.00662 contributor: fullname: NM Carter – volume: 282 start-page: 941 year: 1998 ident: 67_CR45 publication-title: Science doi: 10.1126/science.282.5390.941 contributor: fullname: A Maiti – volume: 26 start-page: 1427 year: 1983 ident: 67_CR22 publication-title: Arthritis Rheum doi: 10.1002/art.1780261203 contributor: fullname: AJ Freemont – volume: 145 start-page: 899 year: 1999 ident: 67_CR11 publication-title: J Cell Biol doi: 10.1083/jcb.145.4.899 contributor: fullname: A Bistrup – volume: 350 start-page: 2572 year: 2004 ident: 67_CR37 publication-title: N Engl J Med doi: 10.1056/NEJMoa032534 contributor: fullname: JC Edwards |
SSID | ssj0017828 |
Score | 1.9988762 |
Snippet | The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive... Abstract Background The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules... Background: The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV... BACKGROUND: The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV... Abstract Background The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules... |
SourceID | doaj pubmedcentral biomedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 6 |
SubjectTerms | Antigens, Surface - biosynthesis Antigens, Surface - genetics Arthritis, Rheumatoid - enzymology Arthritis, Rheumatoid - pathology Carbohydrate Sulfotransferases Cells, Cultured - drug effects Cells, Cultured - metabolism Chemotaxis, Leukocyte - physiology Endothelial Cells - drug effects Endothelial Cells - metabolism Endothelium, Vascular - cytology Humans L-Selectin - physiology Lymphotoxin-alpha - pharmacology Lymphotoxin-beta Membrane Proteins - biosynthesis Membrane Proteins - genetics Membrane Proteins - pharmacology Receptors, Lymphocyte Homing - physiology Sulfotransferases - biosynthesis Sulfotransferases - genetics Synovial Membrane - metabolism Synovial Membrane - pathology Tumor Necrosis Factor-alpha - pharmacology Venules - cytology |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQpSIuiJa_hQI-IG7WdhPHP8cWdbVCak8t6s2yY1sbaXGqTYK678JLwIP0mRg72dKskLhw3NiOvJ7PmW9kzzcIfcwLBm7BW-KyTBLKHCXaSU1MlnFWCi5YSgo7v2CLK_rlurh-UOor3gnr5YH7hZsWs1isW4uS5uC5LTcuYoYawxk9NrxP3TuW22BqOD8Av5eS4ODTS2IJpq26pmDT-2eEEbaT5r4aeack4v835rl7gfKBR5o_Q08HKolP-r9wgB65cIj2--KSm0P0-Hw4Nn-OfpzgxdlXEstwwGcPOCZuupWv20Ra3RocGa4a7G7TpVhorQJeL10HZLauLIY1WibpI9xsQv296r5hHWwcAfE8IMNis8GrDcCibuvbKpC7n9O7X6nP5cUcfsX39Qof0NcFG5O-VoB7HE8Nmhfoan52-XlBhrIMxBS5bIkrjNUFdQbIjKC-nBnvjTaZ8xDdAJs0IrPOlDbnpbTWc-6dpkxwyYSkFga9RHuhDu41wlxrnxXGM2YsxOlWeg2UUBpuSj_LCztBcmQeddNLcKgoij1ugf2pomlVNK1iik3Qp60p74eliEew3Y6n0dCjd6cHAEM1wFD9C4YT9GELEwUbNK6fDq7uGjWLpUyAB07Qqx40f2YDVBkYErTwEZxGMxm3hGqZJMAhaJciF2_-x9TfoidJjzZerONHaK9dd-4dMK3WvE-b6jeWHysS priority: 102 providerName: Directory of Open Access Journals – databaseName: PubMed Central dbid: RPM link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLXaSiA2CMqjU15eIHbuMInjx7JUHY2QpmLRou4iO7aZSBmnmmRQ51_6E_Ah_SauPQmQESuWiR-yfI99z5XvA6H3acZALThDbJJIQpmlRFmpiE4SzgrBBYtBYfMLNruin6-z6z2U9bEw0Wm_0OWJr5YnvlxE38qbZTHu_cTGX-ZnYLJIkYrxPtoHgPYmevd0ACpP9Mk0BRtP4PYloQoTYSTWKwJ-AmpJ7gS4VwO9FNP3_4tz7rpO_qWLpk_Q445E4tPtYp-iPesP0YNtWcnNIXo47x7Mn6G7Uzw7_0pCAQ648IBd4mZdubqNdNWuQIXhssH2NrrDQmvp8Wph10Bj69Jg2I1FTHqEm42vv5frJVbehBFgyQMmDNYbXG0AEHVb35ae3P8Y3_-MfS4vpvAV5tvm9oC-1psQ7lUB4nF4L2ieo6vp-eXZjHQFGYjOUtkSm2mjMmo10BhBXTHRzmmlE-vArgEeqUVirC5MygtpjOPcWUWZ4JIJSQ0MeoEOfO3tEcJcKZdk2jGmDVjoRjoFZFBqrgs3STMzQnIgnvxmm3wjD-mwhy1wMvMg5TxIOWc5G6EPvSh_D4u2jmC7HT8FQQ_mjj_q1be8A1yeTUK1eCUKmgJ1NFzbcGlRrTmjHzWXI_Suh0kORzPsn_K2Xjf5JBQxAQY4Qi-3oPmzmg6EI8QHcBqsZNgCZyEm_-6wf_zfI1-hRzH9bPCj46_RQbta2zdArFr9Nh6kX62jKx8 priority: 500 providerName: National Library of Medicine – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCMQFQXktTx8QN1OSOH4cECqoqxVSe-qi3iI7ttlIIYFkgzb_hT8BP6S_ibGTZcmqN46JH7I8M55v5PE3CL1KUgZuwRli41gSyiwlykpFdBxzlgsuWHgUdnrGFkv66SK92FEKjRvYXhna-XpSy6Z8s_nevweDfxcMXrCjCA5Y4gstEUbYdXQjphCk-yw-urtQAEcYXsVtu27pNveH7717LyfuKrD6XwVF9zMq_3FR87vozogt8fGgDPfQNVsdoptDtcn-EN06He_R76Ofx3hx8pn4uhxwDgLoxG1XunodUKxtwLPhosV2E7JkobWocLOyHaDbujAYtG0VuJBw21f1j6L7ilVl_AgI8EFVDNY9LnvQk3pdb4qKXP46uvwd-pyfzeHLzzdQfkBfWxn_CqwEQ8D-GqF9gJbzk_OPCzLWaSA6TeSa2FQblVKrAd0I6vJIO6eVjq2DcAfgpRaxsTo3Cc-lMY5zZxVlgksmJDUw6CE6qOrKPkaYK-XiVDvGtIHA3UinACNKzXXuoiQ1MyQn4sm-DZwcmWfJnraAwWZetJkXbcYyNkOvt6L8OyyEQILtd_zgBT2ZO_yomy_ZaNBZGvki8krkNAFEabi2_iyjWnNG32ouZ-jlVk0ysFi_f6qydddmka9tAsBwhh4NSrNbDWBngEzQwifqNFnJtKUqVoETHKJ4KRLx5D_25ym6HXhpfYIdf4YO1k1nnwPiWusXwZb-AD2LMW4 priority: 102 providerName: Scholars Portal |
Title | A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-alpha/beta and TNF-alpha in cultured endothelial cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/15752429 https://search.proquest.com/docview/17834639 http://dx.doi.org/10.1186/1471-2172-6-6 https://pubmed.ncbi.nlm.nih.gov/PMC1079838 https://doaj.org/article/516515a8c43441d7be19634bb7640b79 |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagFYgLgvJaHosPiJtVkjh-HLeoq9VK2wstqrhYdmxrI20TtElQ97_wJ-CH9DcxdnZbsuLGJVIydmR5xp5v_PgGoQ9ZzsAteEtcmkpCmaNEO6mJSVPOCsEFi5fCFmdsdkHnl_nlHUnS3g5-IthxAtMnCWmUCCPsPjpMA59KCMtPvt1uF4Cbi3fedkV3ZJr71fduta8Gzihy9v8LaO6fl_zLAU2foMdb5IgnvaqfonuuOkIP-lySmyP0cLHdJX-Gfk7w7PQrCVk3YJYDSImbbuXrNmJUtwa_hcsGu-t4BhakZYXXS9cBdq1Li8GWlpHpCDebqv5RdldYVzbUgPAdDMFis8GrDVhB3dbXZUVufh3f_I5lzs-m8Bb-1xN6QFlX2XDHawVmjsMmQfMcXUxPzz_PyDYLAzF5JlvicmN1Tp0B7CKoLxLjvdEmdR6CGQCPRqTWmcJmvJDWes6905QJLpmQ1EKlF-igqiv3CmGutU9z4xkzFsJyK70GBCgNN4VPstyOkByoR33vGTdU4MAeSmA4qqBaFVSrmGIj9HGnyttqMcARbL_gSVD04N_xAxid2g5XlSchRbwWBc0AL1puXJipqDGc0U-GyxF6vzMTBeMx9J-uXN01KgmZSwD2jdDL3mjuWgPIGAARSPjAnAYtGUqqchkZvyFGlyITr_-jf96gR5F1Nhyf42_RQbvu3DvAU60Zo8PJZP5lPo7rEfBcUDGO42scF7_-AIMBKFk |
link.rule.ids | 108,230,315,730,783,787,867,888,2109,2228,24330,24949,27936,27937,53804,53806,76140,76141 |
linkProvider | BioMedCentral |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKEY8LgvJaXvUBcTNlE8ePY4u6WqC7B7RFFRfLjm020jZBmyzq_hf-BPyQ_ibGzqY0K24cE3siy_P6JvbMIPQ6zRi4BW-JSxJJKHOUaCc1MUnCWS64YDEpbDJl41P68Sw720GjLhfGnOdFSIyI_5TfXk9BX0S73V0Xa7VdsIMhWFcSuiwRRtgNdBPCchoU9PPR16vTBPCCMSWum9rV2twm30p6X_R8VSzp_y8cun2d8pp_Gt1H9zbAEh-2K3-Adly5h261rSbXe-j2ZHOI_hD9PMTj4y8kNOUAIwiIE9erha-aCGHdEtwaLmrsLuIVWRgtSrycuxVA26qwGLZmHgsh4XpdVj-K1TnWpQ0UEN2DnFhs1nixBiGpmuqiKMnlr4PL33HObDqCp_C9tt4HzHWlDSlgC9ACHM4Q6kfodHQ8ez8mmyYNxGSpbIjLjNUZdQagjaA-HxrvjTaJ8xDrALY0IrHO5DblubTWc-6dpkxwyYSkFogeo92yKt1ThLnWPsmMZ8xYiNqt9BoAojTc5H6YZnaAZI896ntbkEOFEtn9ERAVFVirAmsVU2yA3nSsvCKL8Y9g2xOPAqN7344vquU3tZE-lQ1DB3ktcpoCnLTcuGDIqDGc0XeGywHa78REgbqG_dOlq1a1GobGJoAKB-hJKzR_VwPAGfASjPCeOPVW0h8pi3ksCA4hvBSpePYf-7OP7oxnkxN18mH66Tm6GwvUhpt2_AXabZYr9xKgV2NeRb36AxSGM6E |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKERUXBOW15VEfEDezbOL4cWyhy_LoCqEWVVwsO7bZqGlS7QN1_wt_An5IfxNjZ1OaFTduSca2LM-M55vYM4PQizRjYBa8JS5JJKHMUaKd1MQkCWe54ILFoLDDMRsd0w8n2ckGetfGwpizvAiBEfGf8qvrIehl3LfhIT_tn1vfqLtg_QFsrySUWSKMsBvoJvjlNNRw-LL_7eo4AcxgjIlrm7bJNte7r0W9lx1jFXP6_wuIrt-nvGaghnfRnRWyxHuNKNxDG67aRreaWpPLbbR1uDpFv49-7uHRwVcSqnLALgiQE88Wpa_nEcO6Kdg1XMywu4h3ZIFaVHg6cQvAtnVhMcjaJGZCwrNlVf8oFmdYVzb0APceBMVis8TlEqSkntcXRUUuf_Uvf8c2R-MhvIXxmoQf0NZVNsSAlaAGOBwizB6g4-HB0ZsRWVVpICZL5Zy4zFidUWcA2wjq84Hx3miTOA_ODoBLIxLrTG5TnktrPefeacoEl0xIaqHTQ7RZ1ZV7jDDX2ieZ8YwZC267lV4DQpSGm9wP0sz2kOywR503GTlUyJHdpYCsqMBaFVirmGI99LJl5VW36AAJtt5wPzC6M3b8UE-_q5U6q2wQSshrkdMU8KTlxoWdjBrDGX1tuOyh3VZMFOhrWD9duXoxU4NQ2QRgYQ89aoTm72wAOQNgAgrviFNnJl1KVUxiRnDw4aVIxc5_rM8u2vr8dqg-vR9_fIJuxwS14aYdf4o259OFewbQa26eR7X6A4IwM2w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+HEV-restricted+sulfotransferase+is+expressed+in+rheumatoid+arthritis+synovium+and+is+induced+by+lymphotoxin-%CE%B1%2F%CE%B2+and+TNF-%CE%B1+in+cultured+endothelial+cells&rft.jtitle=BMC+immunology&rft.au=Pablos%2C+Jos%C3%A9&rft.au=Santiago%2C+Bego%C3%B1a&rft.au=Tsay%2C+Durwin&rft.au=Singer%2C+Mark&rft.date=2005-03-07&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2172&rft.eissn=1471-2172&rft.volume=6&rft.issue=1&rft.spage=6&rft.epage=6&rft_id=info:doi/10.1186%2F1471-2172-6-6&rft.externalDBID=n%2Fa&rft.externalDocID=oai_biomedcentral_com_1471_2172_6_6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2172&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2172&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2172&client=summon |